
AIM
Healthcare · Biotechnology · $5.7M market cap
$0.1436-0.01 (-3.4%)Nov 13, 4:19 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +75.7% over 90 days · 30-day revisions 1 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 12, 2026 | After the close | -0.09 | -0.21 | -133.3% |
| Aug 7, 2026 | Time not confirmed | -0.12 | -0.43 | -258.3% |
| May 15, 2026 | After the close | -0.37 | -0.69 | -86.5% |
| Nov 17, 2025 | After the close | -0.98 | -1.57 | -60.2% |
| Aug 14, 2025 | After the close | -7.99 | -3.68 | +53.9% |
| May 15, 2025 | After the close | -7.99 | -4.99 | +37.5% |
| Mar 27, 2025 | Time not confirmed | -0.09 | -10.00 | -11011.1% |
| Nov 14, 2024 | After the close | -8.66 | -6.88 | +20.6% |
| Aug 14, 2024 | After the close | -12.32 | -3.00 | +75.6% |
| May 15, 2024 | After the close | -10.99 | -11.99 | -9.1% |
| Nov 14, 2023 | After the close | -10.99 | -16.15 | -47.0% |
| Aug 14, 2023 | After the close | -9.99 | -10.61 | -6.2% |
| May 15, 2023 | Before the open | -0.11 |
AIM ImmunoTech Inc., an immuno-pharma company, engages in the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's flagship products are Ampligen (rintatolimod), a drug of large macromolecular double-stranded ribonucleic acid molecules to treat chronic fatigue syndrome; and Alferon N Injection (Interferon…
| -0.08 |
| +27.3% |
| Mar 31, 2023 | After the close | -11.66 | -9.31 | +20.2% |
| Nov 14, 2022 | After the close | -9.32 | -12.51 | -34.2% |
| Aug 15, 2022 | Before the open | -7.66 | -9.11 | -18.9% |
| May 13, 2022 | After the close | -8.99 | -6.00 | +33.3% |
| Nov 15, 2021 | After the close | -7.99 | -8.14 | -1.9% |
| Aug 16, 2021 | After the close | -8.33 | -7.19 | +13.7% |
| May 17, 2021 | After the close | -8.66 | -7.99 | +7.7% |
| Mar 31, 2021 | Before the open | -0.07 | -0.09 | -28.6% |
| Nov 12, 2020 | After the close | -8.33 | -7.99 | +4.1% |
| Aug 14, 2020 | After the close | -10.99 | -11.71 | -6.6% |
| May 18, 2020 | Time not confirmed | -0.22 | -0.22 | 0.0% |
| Mar 30, 2020 | After the close | -38.30 | -13.99 | +63.5% |
| Nov 14, 2019 | After the close | -96.90 | -112.89 | -16.5% |
| Aug 14, 2019 | After the close | -169.83 | -106.89 | +37.1% |
| May 15, 2019 | After the close | -219.78 | -276.48 | -25.8% |
| Mar 28, 2019 | Time not confirmed | -0.07 | -1.32 | -1785.7% |
| Nov 14, 2018 | After the close | -263.74 | -307.69 | -16.7% |
| Aug 14, 2018 | After the close | — | -2.38 | — |
| May 15, 2018 | After the close | — | -3.29 | — |
| Mar 30, 2018 | After the close | — | -2.67 | — |